Arabic Version of the ICOAP Questionnaire

Completed

• Conditions: Hip Osteoarthritis; Knee Osteoarthritis
• Interventions: Other: Standard treatment

• Registration Number: NCT04648956
• Lead Sponsor: Prince Sultan Military College of Health Sciences

Brief Summary

A study to translate and cross-culturally adapt the Intermittent and Constant Osteoarthritis Pain (ICOAP) measurement tool into the Arabic language, and assess its psychometric properties.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-25
• Study First Submitted: 2020-11-18
• Study First Submitted QC: 2020-11-24
• Study First Posted: 2020-12-02
• Primary Completion: 2022-03-30
• Study Completion: 2022-04-15
• Status Verified: 2022-09
• Last Update Submitted: 2022-09-29
• Last Update Posted: 2022-09-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

• Eligible participants must meet the knee and hip osteoarthritis (OA) diagnostic criteria according to the American College of Rheumatology (ACR).

Exclusion Criteria

1. rheumatoid arthritis
2. serious pathological conditions (inflammatory arthritis and malignancy)
3. total or partial arthroplasty of the affected joint
4. individuals who cannot read and understand documents written in the Arabic language.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Knee/Hip osteoarthritis	Standard treatment	Patients referred for physical therapy rehabilitation

Primary Outcome Measures

Name	Time	Method
Content Validity	1 day	Assessed using the Content Validity Index (CVI) with an acceptable value of at least 0.8.
Construct Validity	1 day	Assessed by calculating the Spearman's correlation coefficient (ρ) between the Arabic ICOAP (ICOAP-Ar) score and the relevant pain and symptoms score of the Knee Injury and Osteoarthritis Outcome Score (KOOS) and Hip Injury and Osteoarthritis Outcome Score (HOOS) measurement tools. The coefficient is classified as follows: ρ = 0.3-0.7 moderate correlation, and \>0.7 strong correlation.
Test-retest Reliability	48-72 hours	Assessed by calculating the intraclass correlation coefficient (ICC) between the ICOAP-Ar scores of the first two test sessions. An ICC value of \>0.8, and 0.6-0.8 will be considered as excellent and good correlation, respectively.
Internal Consistency	48-72 hours	Assessed by calculating the Cronbach's alpha (α) and the corrected item-total correlation. A Cronbach's α value of ≥0.7, and corrected item-total correlation, measured using the Pearson correlation coefficient, of ≥0.3 will be considered acceptable.

Secondary Outcome Measures

Name	Time	Method
Responsiveness	4 weeks	Participants will be categorized according to their reported Global Rating of Change (GRoC) Scale scores to either improved (GRoC ≥3) or stable group (GRoC \<3 to \>-3) and between-group comparison of each group's ICOAP-Ar scores will be performed using unpaired t-test.

Trial Locations

Locations (1)

Prince Sultan Military College of Health Sciences; 🇸🇦 Dhahran, Eastern Province, Saudi Arabia